MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Veracyte DPO Ratio 2011-2025 | VCYT
Annual DPO Ratio Veracyte
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 27.4 | 23.3 | 27.8 | 49.9 | 34.7 | 86.3 | 163 | 153 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 163 | 23.3 | 70.7 |
Quarterly DPO Ratio Veracyte
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 23.3 | 24.2 | 26 | - | 27.8 | 27.8 | 36.9 | - | 49 | 50.5 | 45.5 | - | 34.7 | 35.1 | 54.6 | - | 82.6 | 90.3 | 125 | - | 162 | 170 | 161 | - | 154 | 150 | 118 | - | 43.4 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 170 | 23.3 | 76.9 |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Arbutus Biopharma Corporation
ABUS
|
23 | $ 4.71 | 0.86 % | $ 782 M |  Canada |
 |
Aptorum Group Limited
APM
|
405 | $ 1.3 | - | $ 7.09 M |  China |
 |
Aclaris Therapeutics
ACRS
|
887 | $ 3.25 | -3.27 % | $ 251 M |  USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | USA |
 |
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - |  Russia |
 |
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | Canada |
 |
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
28.5 | $ 25.27 | -2.43 % | $ 1.22 B | USA |
 |
Anika Therapeutics
ANIK
|
54.4 | $ 9.56 | 0.74 % | $ 140 M | USA |
 |
Catalyst Biosciences
CBIO
|
18.8 | $ 14.09 | - | $ 928 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
142 | - | -6.81 % | $ 3.04 B | USA |
 |
Axon Enterprise
AXON
|
29.9 | $ 564.28 | - | $ 42.7 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M |  Israel |
 |
Aytu BioScience
AYTU
|
186 | $ 2.3 | 0.88 % | $ 14.4 M | USA |
 |
AstraZeneca PLC
AZN
|
265 | $ 89.83 | - | $ 96.9 B | Britain |
 |
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
105 | - | -5.38 % | $ 6.06 M | USA |
 |
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
199 | $ 11.53 | - | $ 746 M | USA |
 |
Biogen
BIIB
|
65.4 | $ 174.1 | - | $ 25.3 B | USA |
 |
Abeona Therapeutics
ABEO
|
2.52 K | $ 5.36 | - | $ 115 M | USA |
 |
ADiTx Therapeutics
ADTX
|
5.15 K | $ 2.24 | - | $ 29.5 K | USA |
 |
Berkeley Lights
BLI
|
135 | - | -7.31 % | $ 87 M | USA |
 |
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | USA |
 |
Завод ДИОД
DIOD
|
30.3 | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
306 | - | - | - | Russia |